Volume 31, Number 12—December 2025
Dispatch
Healthcare Worker Attitudes and Perceptions toward Ebola Vaccine, United States, 2024
Figure

Figure. Survey responses from study of healthcare worker attitudes and perceptions toward the Ebola vaccine, United States, 2024. A) Interest in receiving ERVEBO vaccine (Merck, https://www.merck.com) among eligible healthcare workers at New York City Health + Hospitals/Bellevue (New York, NY, USA); University of Texas Medical Branch (Galveston, TX, USA); and Denver Health and Hospital Authority (Denver, CO, USA) (n = 66). B) Preferred timing for receiving ERVEBO among survey respondents who indicated they were interested in receiving vaccine and not already vaccinated (n = 30).
Page created: September 30, 2025
Page updated: January 01, 2026
Page reviewed: January 01, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.